Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 24 | 2024 | 5181 | 1.820 |
Why?
|
Paraproteinemias | 7 | 2022 | 246 | 1.640 |
Why?
|
Necrobiotic Xanthogranuloma | 3 | 2017 | 9 | 0.780 |
Why?
|
Melphalan | 3 | 2023 | 431 | 0.750 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 627 | 0.550 |
Why?
|
Hemolysis | 1 | 2017 | 420 | 0.520 |
Why?
|
Immunoglobulin Isotypes | 1 | 2015 | 158 | 0.520 |
Why?
|
Hematologic Diseases | 1 | 2017 | 498 | 0.460 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2019 | 8428 | 0.410 |
Why?
|
Immunoglobulin A | 1 | 2015 | 992 | 0.410 |
Why?
|
Amyloidosis | 3 | 2023 | 795 | 0.400 |
Why?
|
Xanthomatosis | 1 | 2011 | 32 | 0.400 |
Why?
|
DNA Repair | 2 | 2019 | 2046 | 0.400 |
Why?
|
Emergencies | 1 | 2017 | 1170 | 0.380 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2010 | 45 | 0.360 |
Why?
|
Cryoglobulinemia | 3 | 2016 | 87 | 0.360 |
Why?
|
Waldenstrom Macroglobulinemia | 4 | 2023 | 1052 | 0.360 |
Why?
|
Antigens, Nuclear | 1 | 2010 | 192 | 0.350 |
Why?
|
Antibodies, Antinuclear | 1 | 2010 | 326 | 0.330 |
Why?
|
Sjogren's Syndrome | 1 | 2010 | 233 | 0.320 |
Why?
|
Heart | 2 | 2022 | 4467 | 0.310 |
Why?
|
Skin Diseases | 2 | 2015 | 1065 | 0.300 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2022 | 5442 | 0.300 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3597 | 0.290 |
Why?
|
Antibodies, Monoclonal | 2 | 2021 | 9274 | 0.290 |
Why?
|
Kidney | 3 | 2020 | 7186 | 0.270 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5751 | 0.260 |
Why?
|
Liver | 1 | 2020 | 7474 | 0.250 |
Why?
|
Prognosis | 9 | 2022 | 29063 | 0.190 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2022 | 177 | 0.180 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2019 | 195 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9239 | 0.170 |
Why?
|
Genomic Instability | 2 | 2020 | 695 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 11524 | 0.160 |
Why?
|
Plasmapheresis | 2 | 2016 | 211 | 0.160 |
Why?
|
Xeroderma Pigmentosum | 1 | 2017 | 31 | 0.150 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2010 | 2104 | 0.150 |
Why?
|
Humans | 45 | 2024 | 744343 | 0.140 |
Why?
|
Plasma Exchange | 1 | 2017 | 152 | 0.140 |
Why?
|
Immunoglobulin M | 1 | 2021 | 1537 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2017 | 105 | 0.140 |
Why?
|
p21-Activated Kinases | 1 | 2017 | 128 | 0.140 |
Why?
|
Leukemia, Lymphoid | 1 | 2016 | 315 | 0.140 |
Why?
|
Genome, Human | 2 | 2019 | 4420 | 0.130 |
Why?
|
Cyclophosphamide | 3 | 2016 | 2242 | 0.130 |
Why?
|
Combined Modality Therapy | 4 | 2021 | 8642 | 0.130 |
Why?
|
Stem Cell Transplantation | 2 | 2022 | 1620 | 0.130 |
Why?
|
Hypertension, Portal | 1 | 2017 | 220 | 0.130 |
Why?
|
Autoimmunity | 2 | 2015 | 1349 | 0.130 |
Why?
|
Ubiquitin | 1 | 2019 | 852 | 0.120 |
Why?
|
Survival Rate | 5 | 2020 | 12788 | 0.120 |
Why?
|
Mutagenesis | 1 | 2018 | 1266 | 0.120 |
Why?
|
Aged | 16 | 2021 | 163280 | 0.120 |
Why?
|
Dexamethasone | 5 | 2023 | 1951 | 0.110 |
Why?
|
Immunoglobulin G | 2 | 2014 | 4560 | 0.100 |
Why?
|
Oncogenes | 1 | 2018 | 1265 | 0.100 |
Why?
|
Enhancer Elements, Genetic | 1 | 2018 | 1341 | 0.100 |
Why?
|
Prevalence | 3 | 2024 | 15226 | 0.100 |
Why?
|
Opportunistic Infections | 1 | 2015 | 389 | 0.100 |
Why?
|
DNA Helicases | 1 | 2017 | 859 | 0.100 |
Why?
|
Gene Expression Profiling | 3 | 2018 | 9438 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1813 | 0.100 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 733 | 0.100 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 693 | 0.100 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2015 | 547 | 0.100 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57776 | 0.100 |
Why?
|
Chemokines | 1 | 2015 | 970 | 0.100 |
Why?
|
Transplantation, Autologous | 3 | 2023 | 2124 | 0.090 |
Why?
|
Leukocytes, Mononuclear | 2 | 2017 | 1836 | 0.090 |
Why?
|
Promoter Regions, Genetic | 2 | 2019 | 5867 | 0.090 |
Why?
|
Genomics | 4 | 2019 | 5720 | 0.090 |
Why?
|
Cytokines | 2 | 2015 | 7322 | 0.090 |
Why?
|
Meningitis, Aseptic | 1 | 2009 | 58 | 0.090 |
Why?
|
Salvage Therapy | 1 | 2016 | 1275 | 0.090 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1179 | 0.090 |
Why?
|
Cell Line, Tumor | 4 | 2019 | 16689 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1602 | 0.080 |
Why?
|
Translocation, Genetic | 3 | 2021 | 1420 | 0.080 |
Why?
|
Middle Aged | 11 | 2021 | 213383 | 0.080 |
Why?
|
Fabry Disease | 1 | 2009 | 90 | 0.080 |
Why?
|
Models, Genetic | 1 | 2019 | 3494 | 0.080 |
Why?
|
Veterans | 1 | 2022 | 2519 | 0.080 |
Why?
|
Female | 18 | 2024 | 380194 | 0.080 |
Why?
|
Immunoglobulin Light Chains | 2 | 2023 | 277 | 0.080 |
Why?
|
Survival Analysis | 1 | 2021 | 10252 | 0.080 |
Why?
|
Prospective Studies | 3 | 2024 | 53288 | 0.080 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2727 | 0.080 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1814 | 0.070 |
Why?
|
Kidney Diseases | 2 | 2015 | 2149 | 0.070 |
Why?
|
Male | 15 | 2021 | 350118 | 0.070 |
Why?
|
Monocytes | 1 | 2016 | 2596 | 0.070 |
Why?
|
Adult | 10 | 2024 | 214055 | 0.070 |
Why?
|
Acute Disease | 1 | 2017 | 7149 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3870 | 0.070 |
Why?
|
Bacterial Infections | 1 | 2015 | 1401 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2016 | 1632 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2014 | 1889 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39050 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2022 | 63114 | 0.060 |
Why?
|
Skin | 3 | 2014 | 4364 | 0.060 |
Why?
|
DNA, Neoplasm | 2 | 2020 | 1758 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 9648 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7722 | 0.060 |
Why?
|
Neutrophils | 1 | 2015 | 3719 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2022 | 77449 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 3647 | 0.050 |
Why?
|
Body Size | 1 | 2024 | 461 | 0.050 |
Why?
|
Mutation | 4 | 2021 | 29786 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4186 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5535 | 0.050 |
Why?
|
Models, Biological | 1 | 2016 | 9583 | 0.040 |
Why?
|
Transcription Factor DP1 | 1 | 2018 | 141 | 0.040 |
Why?
|
Macrophages | 1 | 2014 | 5655 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2020 | 279 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3752 | 0.040 |
Why?
|
Thalidomide | 2 | 2015 | 890 | 0.040 |
Why?
|
Germinal Center | 1 | 2021 | 377 | 0.040 |
Why?
|
E2F1 Transcription Factor | 1 | 2018 | 190 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3462 | 0.040 |
Why?
|
Boronic Acids | 2 | 2013 | 965 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3586 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2018 | 10481 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2019 | 457 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 2020 | 509 | 0.040 |
Why?
|
Pyrazines | 2 | 2013 | 1230 | 0.040 |
Why?
|
United States Department of Veterans Affairs | 1 | 2021 | 875 | 0.040 |
Why?
|
Azepines | 1 | 2018 | 336 | 0.040 |
Why?
|
Phenotype | 1 | 2014 | 16365 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 299 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2014 | 21746 | 0.030 |
Why?
|
Cell Communication | 1 | 2023 | 1621 | 0.030 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2017 | 374 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 684 | 0.030 |
Why?
|
Glomerular Basement Membrane | 1 | 2015 | 33 | 0.030 |
Why?
|
Protein Binding | 2 | 2018 | 9386 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2017 | 408 | 0.030 |
Why?
|
Red-Cell Aplasia, Pure | 1 | 2015 | 30 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2009 | 3265 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2019 | 594 | 0.030 |
Why?
|
Lichen Planus, Oral | 1 | 2015 | 56 | 0.030 |
Why?
|
Clone Cells | 1 | 2018 | 1692 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2019 | 1060 | 0.030 |
Why?
|
Common Variable Immunodeficiency | 1 | 2015 | 93 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2014 | 13695 | 0.030 |
Why?
|
Women's Health | 1 | 2024 | 2034 | 0.030 |
Why?
|
Inflammation | 1 | 2014 | 10638 | 0.030 |
Why?
|
Point Mutation | 1 | 2019 | 1623 | 0.030 |
Why?
|
Agammaglobulinemia | 1 | 2015 | 167 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2018 | 970 | 0.030 |
Why?
|
Caspases | 1 | 2017 | 928 | 0.030 |
Why?
|
Risk Factors | 4 | 2024 | 72290 | 0.030 |
Why?
|
Gene Dosage | 1 | 2018 | 1252 | 0.030 |
Why?
|
Thymoma | 1 | 2015 | 186 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2716 | 0.030 |
Why?
|
Fibrinogens, Abnormal | 1 | 2012 | 10 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2016 | 346 | 0.030 |
Why?
|
Cisplatin | 1 | 2019 | 1662 | 0.030 |
Why?
|
Cryoglobulins | 1 | 2012 | 59 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 1941 | 0.030 |
Why?
|
Triazoles | 1 | 2018 | 911 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2183 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 1341 | 0.030 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2012 | 87 | 0.030 |
Why?
|
Leg Ulcer | 1 | 2012 | 69 | 0.030 |
Why?
|
DNA Replication | 1 | 2019 | 1399 | 0.030 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2015 | 659 | 0.030 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2012 | 173 | 0.030 |
Why?
|
Proteinuria | 1 | 2015 | 658 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21683 | 0.030 |
Why?
|
Phylogeny | 1 | 2019 | 2803 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20822 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2019 | 2309 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1783 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18370 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18029 | 0.020 |
Why?
|
Animals | 4 | 2020 | 168757 | 0.020 |
Why?
|
Disease Progression | 2 | 2018 | 13284 | 0.020 |
Why?
|
Mice, Nude | 1 | 2017 | 3689 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2459 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2012 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 40561 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2024 | 12354 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2948 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 2513 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3557 | 0.020 |
Why?
|
Necrosis | 1 | 2012 | 1643 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9146 | 0.020 |
Why?
|
Prednisone | 1 | 2012 | 1574 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 2170 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3505 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2386 | 0.020 |
Why?
|
Stroke | 1 | 2009 | 9981 | 0.020 |
Why?
|
Colitis | 1 | 2015 | 1170 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5882 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13989 | 0.020 |
Why?
|
Body Mass Index | 1 | 2024 | 12720 | 0.020 |
Why?
|
Ischemia | 1 | 2014 | 1907 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4286 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2699 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2009 | 1184 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2020 | 7880 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 1790 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2015 | 2957 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6489 | 0.010 |
Why?
|
Headache | 1 | 2009 | 1226 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4665 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 12745 | 0.010 |
Why?
|
Biopsy | 1 | 2012 | 6756 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9727 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2012 | 1972 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11483 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12261 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11031 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10180 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 20947 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 85781 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23403 | 0.010 |
Why?
|
United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81183 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 35421 | 0.000 |
Why?
|
Concepts
(221)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_